Gem Aromatics is a specialty-ingredients manufacturer that turns natural botanicals and synthetic chemistry into the molecules behind toothpaste, perfume, and pain relief - a business built on distilling plants and then distilling that know-how into ever more complex compounds. It began in 1997 as a single-product, single-customer operation in Silvassa and spent two decades quietly expanding its mint-processing muscle before a 2019 strategic investment by dōTERRA, a global wellness giant, embedded a major customer on its share register and signalled its arrival as a globally compliant platform. The recurring approach is to master one botanical family, forward-integrate into its high-value derivatives using in-house R&D, and then replicate that playbook in the next chemistry - mint begat cooling agents, clove begat eugenol derivatives, and that same logic is now being applied to phenol and citral chemistries at a new greenfield site.
Business segments
A single integrated specialty-ingredients platform with four product families - mint, clove, phenol derivatives, and citral-plus-botanicals - all running on a shared three-facility manufacturing backbone that went fully live in April 2026.
1. Mint and mint derivatives: the cash engine built on India’s mint belt
The company processes roughly one out of every two dollars of mint material India produces, and has forward-integrated from menthol into cooling agents where it now holds the country’s largest installed capacity.
- Rooted in the crop belt - the Budaun facility sits in Uttar Pradesh, India’s prime mint cultivation region, giving the company cost-efficient, short-supply-chain access to peppermint and spearmint raw material that competitors without a local presence cannot easily replicate.
- Scale in a concentrated global market - India supplies roughly 53-55% of the world’s mint derivatives, a market worth about USD 1.8-2.0 billion, and the company’s 3,800 MTPA of installed capacity makes it one of the leading processors in that supply chain.
- From menthol to cooling agents - in-house R&D developed WS-23, WS-03, and a proprietary molecule called GEM Cool 5, which are forward-integrated derivatives of menthol used in oral care and cosmetics; these are now made at the Dahej facility under the Krystal Ingredients subsidiary with 500 MTPA of capacity, the largest cooling-agent line in India.
- Natural and synthetic, same hardware - the company offers both naturally derived and synthetic mint products, and its reactors can switch between the two, so it can serve customers who want natural labelling and those who want cost-consistent synthetic supply from the same asset base.
2. Clove and clove derivatives: the second pillar, scaled on next-generation chemistry
It is one of India’s largest processors of clove oil and eugenol by volume, and has just brought online a vapour-phase technology platform that makes the business faster to switch and cheaper to run.
- A two-decade build - the clove vertical was introduced in 2009 and has grown into the company’s second-largest revenue contributor, processing clove oil, eugenol, and eugenol derivatives for oral care, wellness, pain management, and flavours.
- Small global market, meaningful Indian share - the worldwide clove-derivatives market is estimated at roughly USD 217 million, with India contributing about 13% of supply, and the company’s 1,600 MTPA of installed capacity positions it as a consolidator in a fragmented trade.
- Vapour-phase technology is the upgrade - the Dahej greenfield facility uses next-generation vapour-phase processing for clove oil and eugenol, which delivers higher purity with near-zero effluent compared to conventional liquid-phase methods, and the plant is designed as a multipurpose asset so it can pivot rapidly between clove and other chemistries.
3. Phenol derivatives: a backward-integration bet waiting for raw-material calm
The company can now make its own anisole - the key precursor for synthetic anethole - using a proprietary effluent-free process, but the plant has been held back by volatile phenol prices linked to geopolitics.
- Make the input, capture the margin - the entry into phenol derivatives is driven by a simple backward-integration logic: synthetic anethole, a flavour and fragrance ingredient the company already sells, requires anisole as its main precursor, and making anisole in-house eliminates a supplier dependency.
- Large capacity, deliberately timed - installed capacity stands at 9,800 MTPA, of which 8,800 MTPA was added in April 2026, making it the company’s biggest capacity block by volume even though it contributed only about 1% of revenue in FY26.
- Green process, bumpy feedstock - the manufacturing route uses a sustainable vapour-phase technology developed by the company that produces high-purity output with near-zero effluent, but elevated phenol prices and supply disruption tied to petrochemical feedstock volatility have kept utilisation low.
- Logistics built in - the Dahej plant is located close to phenol supply sources, the Mumbai-Delhi Expressway, and Jawaharlal Nehru Port, so when the plant runs, inbound raw material and outbound exports move with lower freight cost and faster turnaround.
4. Citral chemistry and other botanicals: the R&D-led expansion wedge
The company is the largest processor of eucalyptus oil in India with roughly 58% market share, and is using that same sourcing-and-distillation playbook to push into high-value citral-derived fragrance molecules like Safranal and Damascone.
- Dominant in eucalyptus - the company sources crude eucalyptus and other botanicals from India, Uganda, Rwanda, and China, and its 58% domestic market share in eucalyptus oil processing makes it the gatekeeper for a raw material that flows into cough remedies, balms, and flavours.
- Citral chemistry is the new frontier - Safranal and Damascone, developed through in-house R&D, are citral-derived molecules used in fine fragrances and high-end perfumery; commercial production of Safranal began in February 2026 at the Dahej facility, opening a product category with higher per-kilo value than bulk botanicals.
- A complete-solution provider - across this segment the company offers both natural extracts and synthetic equivalents, and can operate under CRO (contract research), CMO (contract manufacturing), or CDMO (contract development and manufacturing) models depending on what a customer needs, which makes it stickier than a pure-play supplier.
Manufacturing and technology platform
Three factories, 16,171 MTPA of combined capacity, and an R&D team of 13 scientists - the entire platform reached full operational status in April 2026 with the commissioning of the Dahej greenfield, which alone adds 10,871 MTPA of multipurpose capacity and carries a perpetual 15% corporate tax rate.
- Silvassa, the origin facility - operational since 1997 with 1,500 MTPA of capacity, it produces mint, clove, other natural and synthetic ingredients, and phenol, and holds an EcoVadis Platinum sustainability rating, placing it in the top tier globally.
- Budaun, the mint anchor - commissioned in 2016 with 3,800 MTPA of capacity, it is embedded in Uttar Pradesh’s mint cultivation belt and is the primary processing hub for the company’s largest segment.
- Dahej, the multipurpose growth engine - built under wholly owned subsidiary Krystal Ingredients at a total planned capex of roughly INR 270 crores, nearly all of which was capitalised by March 2026, the facility is designed for rapid product changeovers across multiple chemistries and uses next-generation vapour-phase technology.
- Chemistry toolkit - the company’s process technology spans fixed-bed and high-pressure reactors, continuous reaction systems, high-vacuum distillation including wiped-film and short-path units, and complex chemistries such as Grignard’s reactions, Friedel-Crafts, cross-coupling, photochemical reactions, and methoxylation using green chemistry.
- Certifications as a market-access tool - the Dahej facility has completed first-stage audits for FSSC 22000, GHP, HACCP, and ISO 9001/14001/45001, and the company holds ISO 22000:2018 and ISO TS 22002-1:2009 across its operations, which are table-stakes requirements for supplying global FMCG and flavour-and-fragrance houses.
Group structure and partners
A listed Indian parent with two operating subsidiaries and a third being established in Brazil, anchored by a strategic shareholder who is also a key customer.
- Parent and listed entity - Gem Aromatics Ltd trades on BSE and NSE, with its registered office in Mumbai, and is the holding company for all operating assets except the Dahej facility.
- Krystal Ingredients, the Dahej owner - this wholly owned Indian subsidiary holds the 10,871 MTPA Dahej greenfield plant and received a blanket investment approval of up to INR 200 crores from the parent in November 2025 to fund continued operations.
- International subsidiaries - Gem Aromatics LLC in the USA handles distribution in the American market, and a third wholly owned subsidiary in Brazil was approved in June 2026 to distribute essential oils and specialty chemicals across Latin America, with an equity investment of up to INR 2 crores and a standby letter of credit of up to INR 15 crores.
- dōTERRA, the strategic anchor - dōTERRA Enterprises, Sàrl made a strategic investment in 2019 and is both a shareholder and a major customer, creating an alignment where a significant buyer is economically invested in the company’s manufacturing quality and capacity expansion.